Covid-19 | Extension of Market Access to Life-Saving and Life-Extending Drugs

COVID-19 is raising the issue on the extension of market access to some critical life-saving and life-extending drugs.

In this Newsletter, we provide a broad picture of the situation and make certain recommendations. including: (i) the background; (ii) the reasons for this problem; (iii) what happened in the past; (iv) available legislative options for current situation; (v) recommendations; and (vi) conclusion.